All subscribers received an option trade strategy on these obesity drug stocks: Arena Pharmaceuticals (ARNA), Vivus Inc. (VVUS), and Orexigen Therapeutics (OREX).
VVUS has a date with the FDA on September 28th and OREX December 7th.
VVUS has a date with the FDA on September 28th and OREX December 7th.
9 comments:
I think ARNA will be extended, VVUS looks bleak and OREX not convinced of. Sudeep ")
thanx, cd and brian
nice image fellas, keithster69
That is my thought as well, Q paid 4, thanx. Mo in NJ. and thank you Adam 4 all the work you did for me, FREE 2!
Back after being away for the last qtr. I look forward to your trades- drug stocks- I prefer, DNDN caught my attention first-Dr.Nurel Choudhury-
like arena, but scared abt the fda, sanjaj in ND
Sanj, ARNA failed and now the other ones look good in my eyes. Craig I Am.
made a ton o doe not trading arena that is lower by 37&! OUCH!, glad i sent you the q...nice response, analyst007
POTC you guys rule, end of story. Mike in Miami.
Post a Comment